Share Name Share Symbol Market Type Share ISIN Share Description
International Biotechnology Trust LSE:IBT London Ordinary Share GB0004559349 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +4.00p +0.61% 656.00p 656.00p 660.00p 662.00p 662.00p 662.00p 34,442 16:35:13
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.0 -1.8 -5.1 - 248.44

International Biotechnology Share Discussion Threads

Showing 151 to 170 of 475 messages
Chat Pages: Latest  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
03/3/2010
13:11
This thread includes charts etc
davebowler
09/2/2010
13:12
http://www.internationalbiotrust.com/fact_sheets/2009/January%202010.pdf
davebowler
13/11/2008
12:09
romi2nikki1...........It is a puzzle why the IBT share price has not responded to the recent increase in NAV. The company has declared an objective of maintaining the discount at no greater than 8%. To that end, they have recently bought back 5% of the shares into treasury at 20% discount. In addition, they do not hedge currency. Ongoing depreciation of GBP against USD is offsetting significantly any fall in underlying US asset values. Two good reasons to expect a correction.
foster
12/11/2008
20:48
Discount seems wide on historical basis, and considerably wider than discount on the Frostrow Trust ( biog). Biog much more volatile range, whereas a steady widening IBT. Consider that it is because IBT holds much more unquoted, but as long been the case. Excellent detail on IBT site, much more detail on pipeline progression and cashburn of holdings.
romi2nikki1
23/1/2007
21:33
see http://www.investorwords.com/5431/C_shares.html seems A shares incur a buying fee, B shares a selling fee & C shares an ongoing charge - which I'd have thought applied to most IT's prospectus http://www.internationalbiotrust.com/press_releases/issue_equity.pdf esp end page 2, & 3 take it the C shares will be invested separately then the portfolios combined in ratio to the NAV's achieved can see the point of the offer to raise cash DYOR & NAI!!
gurp
16/1/2007
20:34
Can anybody help me .What is a C share?
21up
13/11/2006
09:34
unfortunately now at a slight premium to nav, small bios in vogue with large pharmas looking for new products
gurp
11/10/2006
17:56
Information needed.Is MW talking about IBT?Thanks
21up
10/10/2006
14:15
Still going up. Was going to dump this one, but now hanging on!
duden1
04/10/2006
21:13
I've noticed that whilst my miners and oils are bombing all my biotechs are ticking up from a very bad slump. I reckon IBT is pretty safe - probably won't be spectacular either up or down. cheerio pg
planetgong
04/10/2006
20:29
My daughter's wedding has been & gone,got a few quid spare,is IBT a good bet?
21up
01/9/2006
14:31
see IBT is starting an upward move presumably on the news of the use of genetically modified imune cells to fight skin cancer.
rogerl
05/5/2006
22:24
No mention of IBT on Mike Walters - different Investment trust entirely!
anakin54321
05/5/2006
22:08
Without sounding to cheeky,i take it Michael Walters has just posted something on IBT.Does anybody know what it says?Thanks
21up
03/5/2006
11:22
thanks fickena,hadnt shown on watchlist.
j4ckthehat
03/5/2006
11:16
Material Change to NAV RNS Number:3411C Intl. Biotechnology Trust PLC 03 May 2006 3 May 2006 MATERIAL CHANGE IN NET ASSET VALUE The Board of International Biotechnology Trust plc (the "Company") notes that due to two events within the portfolio, one of which is currently bound by confidentiality, the net asset value ("NAV") of the Company has, on a net basis, materially increased. The events, had they been incorporated into the last released NAV of 25 April 2006, would have increased the NAV per share by 11.64p, or, 8.18%. One of the events is the write down of Trine Pharmaceuticals from #1.3m to zero as a result of its uncertain financing position. Further comment on the other confidentiality-bound event will be released as it becomes available.
fickena
03/5/2006
10:57
a nice jump this morning?
j4ckthehat
10/3/2006
15:54
Bought in today for long term, my reason is that Biotech in general has had a poor 3 years but it seems various breakthroughs in treatments of alkzeimers, parkinsons, and various cancers to say nothing of future possibilities to regenerate failing body parts will send the whole industry northwards in a most satifying way.
rogerl
08/2/2006
18:38
Creeping up
21up
30/1/2006
13:27
Wait till August in my view. They're showing signs of multi year break out. I'm in at 119.I'm biased though, this was one of my best trade of all time, bought at.44 in Decembewr 1998, sold at 3.4 Feb 2000. Spread at this time is very tight for this stock, a goos sign in my view.
kingfast
Chat Pages: Latest  7  6  5  4  3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20180816 16:19:47